Kathryn E. Falberg
Board Member
Nuvation Bio Inc. (NUVB)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Kathryn E. Falberg
Kathryn E. Falberg is recorded as Board Member at Nuvation Bio Inc. (NUVB). Kathryn E. Falberg was last confirmed as Board Member at UroGen Pharma Ltd. (URGN) in a filing dated April 28, 2021. Earlier roles on record: Board Member at Trade Desk, Inc. (TTD) until March 23, 2026. Trade Desk, Inc. reported in an 8-K filed March 25, 2026 that Kathryn E. Falberg resigned as the Board, effective March 23, 2026.
“On March 23, 2026, Ms. Falberg informed the Company of her decision to resign from the Board, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
2016-01-01–2026-03-23
-
2016-01-01–2026-03-23
-
Start not stated–2021-04-28
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Nuvation Bio Inc.
Other people whose current roles at this company are on record from its filings.
- David Hung CEO, Board Member
- Moses Makunje CFO, Chief Accounting Officer
- Philippe Sauvage CFO
- Dr. Junyuan (Jerry) Wang Board Member
- Dr. Xiangmin (Min) Cui, Ph.D. Board Member
- Kim Blickenstaff Board Member
- Min Cui Board Member
- Robert B. Bazemore Board Member
- Robert Mashal Board Member
- Robert Mashal, M.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.